BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26130461)

  • 41. [Epigenetic markers of esophageal cancer: DNA methylation].
    Kit OI; Vodolazhskiy DI; Kolesnikov EN; Timoshkina NN
    Biomed Khim; 2016 Jul; 62(5):520-526. PubMed ID: 27797326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer.
    Campan M; Moffitt M; Houshdaran S; Shen H; Widschwendter M; Daxenbichler G; Long T; Marth C; Laird-Offringa IA; Press MF; Dubeau L; Siegmund KD; Wu AH; Groshen S; Chandavarkar U; Roman LD; Berchuck A; Pearce CL; Laird PW
    PLoS One; 2011; 6(12):e28141. PubMed ID: 22163280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of key genes in ovarian cancer treated with decitabine based on network strategy.
    Wang YZ; Qiu SC
    Oncol Rep; 2016 Jun; 35(6):3548-58. PubMed ID: 27035425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetic regulation of cancer-associated genes in ovarian cancer.
    Kwon MJ; Shin YK
    Int J Mol Sci; 2011 Jan; 12(2):983-1008. PubMed ID: 21541038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minireview: epigenetic changes in ovarian cancer.
    Balch C; Fang F; Matei DE; Huang TH; Nephew KP
    Endocrinology; 2009 Sep; 150(9):4003-11. PubMed ID: 19574400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting cancer epigenetics: Linking basic biology to clinical medicine.
    Shinjo K; Kondo Y
    Adv Drug Deliv Rev; 2015 Dec; 95():56-64. PubMed ID: 26494398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Role of DNA Methylation in Cancer.
    Lakshminarasimhan R; Liang G
    Adv Exp Med Biol; 2016; 945():151-172. PubMed ID: 27826838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis.
    Ho CM; Shih DT; Hsiao CC; Huang SH; Chang SF; Cheng WF
    J Transl Med; 2015 Nov; 13():367. PubMed ID: 26597084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis.
    Feng LY; Chen CX; Li L
    Medicine (Baltimore); 2019 Feb; 98(8):e14588. PubMed ID: 30813180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic targeting of ovarian cancer stem cells.
    Wang Y; Cardenas H; Fang F; Condello S; Taverna P; Segar M; Liu Y; Nephew KP; Matei D
    Cancer Res; 2014 Sep; 74(17):4922-36. PubMed ID: 25035395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intratumor Heterogeneity in Breast Cancer.
    Beca F; Polyak K
    Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of candidate epigenetic biomarkers for ovarian cancer detection.
    Huang YW; Jansen RA; Fabbri E; Potter D; Liyanarachchi S; Chan MW; Liu JC; Crijns AP; Brown R; Nephew KP; van der Zee AG; Cohn DE; Yan PS; Huang TH; Lin HJ
    Oncol Rep; 2009 Oct; 22(4):853-61. PubMed ID: 19724865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA methylation marker to estimate ovarian cancer cell fraction.
    Ebata T; Yamashita S; Takeshima H; Yoshida H; Kawata Y; Kino N; Yasugi T; Terao Y; Yonemori K; Kato T; Ushijima T
    Med Oncol; 2022 Feb; 39(5):78. PubMed ID: 35195779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer.
    Balch C; Nephew KP
    Cancer Biomark; 2010-2011; 8(4-5):203-21. PubMed ID: 22045354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrative network analysis of TCGA data for ovarian cancer.
    Zhang Q; Burdette JE; Wang JP
    BMC Syst Biol; 2014 Dec; 8():1338. PubMed ID: 25551281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic markers of ovarian cancer.
    Barton CA; Clark SJ; Hacker NF; O'Brien PM
    Adv Exp Med Biol; 2008; 622():35-51. PubMed ID: 18546617
    [No Abstract]   [Full Text] [Related]  

  • 57. Exploiting Epigenetic Alterations in Prostate Cancer.
    Baumgart SJ; Haendler B
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CGPredictor: a systematic integrated analytic tool for mining and examining genome-scale cancer independent prognostic epigenetic marker panels.
    Cheng WS; Chiang JH
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S10. PubMed ID: 24565108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigenetics in ovarian cancer.
    Natanzon Y; Goode EL; Cunningham JM
    Semin Cancer Biol; 2018 Aug; 51():160-169. PubMed ID: 28782606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Translating cancer epigenomics into the clinic: focus on lung cancer.
    Mari-Alexandre J; Diaz-Lagares A; Villalba M; Juan O; Crujeiras AB; Calvo A; Sandoval J
    Transl Res; 2017 Nov; 189():76-92. PubMed ID: 28644958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.